These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35068931)

  • 1. Cyclic RGD-Decorated Liposomal Gossypol AT-101 Targeting for Enhanced Antitumor Effect.
    Liu H; Zhang R; Zhang D; Zhang C; Zhang Z; Fu X; Luo Y; Chen S; Wu A; Zeng W; Qu K; Zhang H; Wang S; Shi H
    Int J Nanomedicine; 2022; 17():227-244. PubMed ID: 35068931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-Ligand-Functionalized Liposomes Based on Glycyrrhetinic Acid and cRGD for Hepatocellular Carcinoma Targeting and Therapy.
    Qiu M; Wang J; Bai J; Li X; Tian C; Liu Z; Zheng C; Clark AR; Cheng X; Liao X; Wu S; Lee RJ; Zhou X
    Mol Pharm; 2023 Apr; 20(4):1951-1963. PubMed ID: 36952242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects.
    Song Z; Lin Y; Zhang X; Feng C; Lu Y; Gao Y; Dong C
    Int J Nanomedicine; 2017; 12():1941-1958. PubMed ID: 28331317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined integrin α
    Qi N; Zhang S; Zhou X; Duan W; Gao D; Feng J; Li A
    J Nanobiotechnology; 2021 Dec; 19(1):446. PubMed ID: 34949198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.
    Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z
    Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region.
    Amin M; Mansourian M; Koning GA; Badiee A; Jaafari MR; Ten Hagen TLM
    J Control Release; 2015 Dec; 220(Pt A):308-315. PubMed ID: 26526970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin α
    Fu S; Zhao Y; Sun J; Yang T; Zhi D; Zhang E; Zhong F; Zhen Y; Zhang S; Zhang S
    Colloids Surf B Biointerfaces; 2021 May; 201():111623. PubMed ID: 33636597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Targeted cRGD-Coated Liposomes Encapsulating Optimized Synergistic Cepharanthine and IR783 for Chemotherapy and Photothermal Therapy.
    Wu Y; Zeng C; Lv J; Li H; Gao J; Liu Z; Yuan Z
    Int J Nanomedicine; 2024; 19():6145-6160. PubMed ID: 38911506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats.
    Chen Z; Deng J; Zhao Y; Tao T
    Int J Nanomedicine; 2012; 7():3803-11. PubMed ID: 22888235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time near-infrared fluorescence imaging using cRGD-ZW800-1 for intraoperative visualization of multiple cancer types.
    Handgraaf HJM; Boonstra MC; Prevoo HAJM; Kuil J; Bordo MW; Boogerd LSF; Sibinga Mulder BG; Sier CFM; Vinkenburg-van Slooten ML; Valentijn ARPM; Burggraaf J; van de Velde CJH; Frangioni JV; Vahrmeijer AL
    Oncotarget; 2017 Mar; 8(13):21054-21066. PubMed ID: 28416744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting tumors with cyclic RGD-conjugated lipid nanoparticles loaded with an IR780 NIR dye: In vitro and in vivo evaluation.
    Choi J; Rustique E; Henry M; Guidetti M; Josserand V; Sancey L; Boutet J; Coll JL
    Int J Pharm; 2017 Nov; 532(2):677-685. PubMed ID: 28279737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
    Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
    Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes.
    Dicheva BM; ten Hagen TL; Seynhaeve AL; Amin M; Eggermont AM; Koning GA
    Pharm Res; 2015 Dec; 32(12):3862-76. PubMed ID: 26202516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII.
    Lu L; Ding Y; Zhang Y; Ho RJ; Zhao Y; Zhang T; Guo C
    Int J Nanomedicine; 2018; 13():1927-1944. PubMed ID: 29636610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy.
    Chen L; Liu Y; Wang W; Liu K
    Oncol Lett; 2015 Jul; 10(1):77-84. PubMed ID: 26170980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of RGD-modified liposome as a targeted colorectal carcinoma therapy and its autophagy mechanism.
    Ren Y; Yuan B; Hou S; Sui Y; Yang T; Lv M; Zhou Y; Yu H; Li S; Peng H; Chang N; Liu Y
    J Drug Target; 2021 Sep; 29(8):863-874. PubMed ID: 33507113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclo(RGD)-Decorated Reduction-Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In Vivo.
    Chen W; Zou Y; Zhong Z; Haag R
    Small; 2017 Feb; 13(6):. PubMed ID: 27865044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR/NIRF Dual-Mode Imaging of αvβ3 Integrin-Overexpressing Tumors Using a Lipopeptide-Based Contrast Agent.
    Wang Q; Huang L; Zhu X; Zhou Y; Wang J; Su D; Liu L
    Mol Pharm; 2021 Dec; 18(12):4543-4552. PubMed ID: 34677979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword.
    Shuhendler AJ; Prasad P; Leung M; Rauth AM; Dacosta RS; Wu XY
    Adv Healthc Mater; 2012 Sep; 1(5):600-8. PubMed ID: 23184795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo.
    Zhu Y; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
    J Control Release; 2016 Jul; 233():29-38. PubMed ID: 27178807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.